Antibiotics Strategic Business Report 2024: Rising Demand in Emerging Economies Accelerates Demand, Narrow-Spectrum Antibiotics Spurs Innovation in Targeted Therapy - Forecast to 2030
01 août 2024 09h40 HE
|
Research and Markets
Dublin, Aug. 01, 2024 (GLOBE NEWSWIRE) -- The "Antibiotics - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for Antibiotics is...
Paratek Pharmaceuticals Completes Five-Year Microbiologic Surveillance Study of NUZYRA® (omadacycline) Demonstrating No Change in In Vitro Potency Against Indicated Pathogens
31 juil. 2024 07h30 HE
|
Paratek Pharmaceuticals, Inc.
Paratek Pharmaceuticals Completes Five-Year Microbiologic Surveillance Study of NUZYRA® (omadacycline)
Antibacterial Drugs Research - Global Strategic Business Report to 2030 Featuring Allergan, AstraZeneca, Bayer, BMS, GSK, Johnson & Johnson, Merck, Novartis, Pfizer,
26 juil. 2024 06h27 HE
|
Research and Markets
Dublin, July 26, 2024 (GLOBE NEWSWIRE) -- The "Antibacterial Drugs - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for Antibacterial...
Paratek Pharmaceuticals Announces Positive Top-line Efficacy and Safety Data from Post-Marketing Study of NUZYRA® (omadacycline) for Patients with Moderate to Severe Community-Acquired Bacterial Pneumonia
18 juil. 2024 07h30 HE
|
Paratek Pharmaceuticals, Inc.
Paratek Pharmaceuticals Announces Positive Top-line Efficacy and Safety Data from Post-Marketing Study of NUZYRA®
Penicillin Drug Market Is Expected To Reach a Revenue Of USD 13.4 Bn By 2033, at 3.8% CAGR: Dimension Market Research
01 juil. 2024 11h48 HE
|
Dimension Market Research
New York, July 01, 2024 (GLOBE NEWSWIRE) -- Overview The global Penicillin Drug Market is predicted to reach a size of over USD 9.6 billion by 2024, and then it is expected to grow to more than USD...
Antibiotic Resistance Markets Therapeutics, by Pathogen and Therapy Type to 2027: Search for Alternatives to Antibiotics Creates New Global Goldrush
27 mai 2024 03h01 HE
|
Research and Markets
Dublin, May 27, 2024 (GLOBE NEWSWIRE) -- The "Antibiotic Resistance Markets - Therapeutics by Pathogen and Therapy Type. With Situation Analysis, Executive & Investor Guides & Customization....
Ampicillin Market Is Expected To Reach A Revenue Of USD 480.1 Mn By 2033, At 2.4% CAGR: Insights by Dimension Market Research
21 mai 2024 13h49 HE
|
Dimension Market Research
New York, May 21, 2024 (GLOBE NEWSWIRE) -- Overview The Global Ampicillin Market size is expected to reach USD 388.1 million by 2024 and is further anticipated to reach USD 480.1 million by...
Methicillin-Resistant Staphylococcus aureus (MRSA) Epidemiology Analysis and Forecast to 2033
15 mai 2024 04h41 HE
|
Research and Markets
Dublin, May 15, 2024 (GLOBE NEWSWIRE) -- The "Methicillin-Resistant Staphylococcus aureus (MRSA) Epidemiology Analysis and Forecast to 2033" report has been added to ResearchAndMarkets.com's...
Antibiotic Collaboration and Licensing Deals Analysis Report 2024 with Directory of 133 Agreements Signed Since 2019
07 mai 2024 06h41 HE
|
Research and Markets
Dublin, May 07, 2024 (GLOBE NEWSWIRE) -- The "Antibiotic Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering.Antibiotic Collaboration and...
Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections Global Clinical Trials Review 2024: G7 & E7 Regional Insights, Phase, Trial Status, End-points Status and Sponsor Type
29 avr. 2024 07h47 HE
|
Research and Markets
Dublin, April 29, 2024 (GLOBE NEWSWIRE) -- The "Methicillin-Resistant Staphylococcus aureus (MRSA) Infections - Global Clinical Trials Review, 2024" clinical trials has been added to ...